IL267243A - Heparanase inhibitors and use thereof - Google Patents

Heparanase inhibitors and use thereof

Info

Publication number
IL267243A
IL267243A IL267243A IL26724319A IL267243A IL 267243 A IL267243 A IL 267243A IL 267243 A IL267243 A IL 267243A IL 26724319 A IL26724319 A IL 26724319A IL 267243 A IL267243 A IL 267243A
Authority
IL
Israel
Prior art keywords
heparanase inhibitors
heparanase
inhibitors
Prior art date
Application number
IL267243A
Other languages
Hebrew (he)
Original Assignee
Beta Therapeutics Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2017902346A external-priority patent/AU2017902346A0/en
Application filed by Beta Therapeutics Pty Ltd filed Critical Beta Therapeutics Pty Ltd
Publication of IL267243A publication Critical patent/IL267243A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/95Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL267243A 2016-12-13 2019-06-11 Heparanase inhibitors and use thereof IL267243A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662433639P 2016-12-13 2016-12-13
AU2017902346A AU2017902346A0 (en) 2017-06-20 Methods of treating ocular disorders
PCT/AU2017/000271 WO2018107201A1 (en) 2016-12-13 2017-12-13 Heparanase inhibitors and use thereof

Publications (1)

Publication Number Publication Date
IL267243A true IL267243A (en) 2019-08-29

Family

ID=67148292

Family Applications (1)

Application Number Title Priority Date Filing Date
IL267243A IL267243A (en) 2016-12-13 2019-06-11 Heparanase inhibitors and use thereof

Country Status (4)

Country Link
EP (1) EP3555071A4 (en)
AU (2) AU2017376818A1 (en)
IL (1) IL267243A (en)
WO (1) WO2018107201A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12285407B2 (en) 2018-11-21 2025-04-29 The University Of The West Indies Bis-indolylmethane derivatives and uses thereof
CN118852197B (en) * 2024-06-27 2025-09-05 常州康安生物科技有限公司 Apigenin derivative and its preparation method and application

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668787A (en) * 1985-12-20 1987-05-26 Ortho Pharmaceutical Corporation 5,6-dialkoxy-4-imino-2(1H)quinazolinone derivatives
EP0594877A1 (en) * 1992-10-26 1994-05-04 National Science Council Imidazo(1,2-c)quinazoline derivates as antihyper tensives and anti dysurics
GT199900185A (en) * 1998-11-06 2001-04-18 NOVEDOSA PIRIMIDIN-4-ENAMINE AS A FUNGICIDE.
ATE468336T1 (en) * 2002-03-15 2010-06-15 Vertex Pharma AZOLYLAMINOAZINE AS PROTEIN KINASE INHIBITORS
US7928111B2 (en) * 2007-06-08 2011-04-19 Senomyx, Inc. Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors
KR101646960B1 (en) * 2007-10-16 2016-08-09 프로젠 피지500 시리즈 피티와이 리미티드 Novel sulfated oligosaccharide derivatives

Also Published As

Publication number Publication date
WO2018107201A1 (en) 2018-06-21
AU2022201731B2 (en) 2024-03-28
EP3555071A4 (en) 2020-06-10
AU2022201731A1 (en) 2022-04-07
EP3555071A1 (en) 2019-10-23
AU2017376818A1 (en) 2019-07-11

Similar Documents

Publication Publication Date Title
IL265922A (en) Tyk2 inhibitors and uses thereof
IL266109A (en) Tyk2 inhibitors and uses thereof
IL261606A (en) Substituted inhibitors of menin-mll and methods of use
IL267291B (en) Ectonucleotidase inhibitors and methods of use thereof
SG11202000714QA (en) Tyk2 inhibitors and uses thereof
GB201605126D0 (en) Inhibitors and their uses
IL282482A (en) Protoxin-ii variants and methods of use
GB201615282D0 (en) Tankyrase inhibitors
IL258500A (en) Combination therapy with glutaminase inhibitors and immuno-oncology agents
IL267238A (en) Heparanase inhibitors and use thereof
SMT202300256T1 (en) Lrrc33 inhibitors and use thereof
SMT202300381T1 (en) Lsd1 inhibitors and medical uses thereof
IL282508A (en) Protoxin-ii variants and methods of use
IL254916B (en) Inhibitors and their uses
IL255530A (en) Efflux-pump inhibitors and therapeutic uses thereof
IL251077B (en) Integrin inhibitors and their use
IL251078A0 (en) Integrin inhibitors and their use
IL267243A (en) Heparanase inhibitors and use thereof
ZA201803212B (en) Gelatinase inhibitors and use thereof
GB201509977D0 (en) Dispensers and methods of use thereof
GB2545167B (en) Cloches and use thereof
GB201505975D0 (en) Inhibitors and their uses
GB201505971D0 (en) Inhibitors and their uses
AU2014900775A0 (en) Heparanase inhibitors and uses thereof
GB201404335D0 (en) Selective glycosidase inhibitors and uses thereof